Pharmaceutical

Transforming Patient Recruitment: AI and Digital Strategies to Engage the Unreachable 95%, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how AI can streamline patient recruitment and reach the unreachable. Attendees will gain insight into…

5 months ago

ArcheHealth™ to Showcase AI-Powered Healthcare Supply Chain Solution at AHRMM25

Novel solution delivers numerous financial and operational benefits, including insights that improve cash flow, reduce supply and labor costs, and…

5 months ago

ArisGlobal Achieves Strong Global Growth and Continued Innovation in First Half 2025

Expanding Impact of LifeSphere® NavaX™ Across the Industry, 27 Go-Lives, and New Global Pharma Adoptions BOSTON, July 29, 2025 /PRNewswire/…

5 months ago

Unlearn Appoints Its First Vice President of Product

Kwame Marfo brings more than 15 years of experience at the intersection of life sciences, health technology, and product innovationSAN…

5 months ago

Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference

SEATTLE and VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty…

5 months ago

Quoin Pharmaceuticals Provides Product Portfolio Update

Lead Product, QRX003, Being Tested in Two Active Registrational Clinical Studies for Netherton Syndrome Across the U.S., Europe, and the…

5 months ago

Therini Bio Announces First Patient Dosed in Phase 1b Trial of THN391 in Alzheimer’s Disease

- Pioneering approach to halting the chronic neuroinflammation responsible for neurodegeneration- Trial to assess safety, PK and detect early signs…

5 months ago

Daré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY™ Sildenafil Cream

A first-of-its-kind solution for women’s arousal in a proprietary topical formulation demonstrated to work where women need it most Targeted…

5 months ago

Cingulate Receives $4.3M Waiver from FDA Ahead of Imminent Filing for Marketing Approval of Lead ADHD Asset CTx-1301

PDUFA Fee Waiver comes Days before Planned Submission of New Drug ApplicationKANSAS CITY, Kan., July 29, 2025 (GLOBE NEWSWIRE) --…

5 months ago

Praxis Precision Medicines to Host Conference Call to Announce Topline Results from the RADIANT Trial and Provide Second Quarter 2025 Financial Results

BOSTON, July 29, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights…

5 months ago